Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.

Researchers at the Stanford University School of Medicine have developed a molecular probe that sets aglow tumor cells within living animals. Their goal is to use the probe to improve the diagnosis and treatment of cancer and other diseases.

A new technology for cancer detection that eliminates the need for drawing blood has been developed by Purdue University researchers.

Researchers at the University of Pennsylvania School of Medicine have found that a commonly prescribed diabetes drug kills tumor cells that lack a key regulatory gene called p53. Results from current studies in mice may result in new therapies for a subset of human cancers that tend to be aggressive and resistant to existing treatments.

Cancer patients don’t have time to waste. Many go through several different treatments, however, to find one that is more effective against their particular type of tumor.

A Swiss-based research team has published a new mechanistic description of how tumor cells migrate to the lymphatic system in the early stages of tumor metastasis. This new understanding holds significant potential for developing anti-metastasis therapies.

An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.

The number of lymph nodes removed and examined for tumor cells appears to be associated with the likelihood of survival after surgery in colon cancer patients, according to a study in the March 21 Journal of the National Cancer Institute. Health care providers should consider the number of lymph nodes that were removed and evaluated when examining the quality of care that colon cancer patients receive, according to the paper's authors.